Current and emerging options for taxol production Y Li, G Zhang, BA Pfeifer Biotechnology of isoprenoids, 405-425, 2015 | 60 | 2015 |
Directed vaccination against pneumococcal disease Y Li, A Hill, M Beitelshees, S Shao, JF Lovell, BA Davidson, PR Knight III, ... Proceedings of the National Academy of Sciences 113 (25), 6898-6903, 2016 | 48 | 2016 |
Heterologous production of plant-derived isoprenoid products in microbes and the application of metabolic engineering and synthetic biology Y Li, BA Pfeifer Current opinion in plant biology 19, 8-13, 2014 | 45 | 2014 |
Tailoring pathway modularity in the biosynthesis of erythromycin analogs heterologously engineered in E. coli G Zhang, Y Li, L Fang, BA Pfeifer Science Advances 1 (4), e1500077, 2015 | 44 | 2015 |
Comprehensive vaccine design for commensal disease progression CH Jones, G Zhang, R Nayerhoda, M Beitelshees, A Hill, P Rostami, Y Li, ... Science Advances 3 (10), e1701797, 2017 | 32 | 2017 |
In situ pneumococcal vaccine production and delivery through a hybrid biological-biomaterial vector Y Li, M Beitelshees, L Fang, A Hill, MK Ahmadi, M Chen, BA Davidson, ... Science Advances 2 (7), e1600264, 2016 | 27 | 2016 |
Deoxysugar pathway interchange for erythromycin analogues heterologously produced through Escherichia coli M Jiang, H Zhang, SH Park, Y Li, BA Pfeifer Metabolic Engineering 20, 92-100, 2013 | 25 | 2013 |
Enhancing vaccine effectiveness with delivery technology M Beitelshees, Y Li, BA Pfeifer Current opinion in biotechnology 42, 24-29, 2016 | 12 | 2016 |
Bimodal targeting using sulfonated, mannosylated PEI for combined gene delivery and photodynamic therapy U Chitgupi, Y Li, M Chen, S Shao, M Beitelshees, MJ Tan, ... Photochemistry and photobiology 93 (2), 600-608, 2017 | 7 | 2017 |
Antigen delivery format variation and formulation stability through use of a hybrid vector M Beitelshees, A Hill, Y Li, M Chen, MK Ahmadi, RJ Smith Jr, ... Vaccine: X 1, 100012, 2019 | 3 | 2019 |